Information  X 
Enter a valid email address

Xenetic Biosciences (XEN)

  Print      Mail a friend

Thursday 08 September, 2011

Xenetic Biosciences

Change of Name

RNS Number : 8392N
Xenetic Biosciences PLC
08 September 2011


Xenetic Biosciences plc

(formely Lipoxen plc)


Change of name


Xenetic Biosciences plc (AIM: XEN.L), the bio-pharmaceutical company specialising in the development of high-value differentiated biologic drugs and vaccines, announces that following shareholder approval at the General Meeting on 1 September 2011 to change the Company's name the change of name has become effective as Companies House has issued the certificate of incorporation on change of name.


The Company now trades on AIM under the name Xenetic Biosciences plc and the ticker XEN. The new Company website is now live and can be viewed at



Xenetic Biosciences plc


M. Scott Maguire, Chief Executive Officer

+44 (0)20 7389 5015

Singer Capital Markets (NOMAD & Broker)

+44 (0)20 3205 7500

Jeff Keating / Claes Spång

Walbrook PR

+44 (0)20 7933 8780 

Paul McManus

Paul Cornelius




This information is provided by RNS
The company news service from the London Stock Exchange